Showing results (161-170 of 458) with videos related to
Sort By:
Pageof 46
Family Practice|September 5, 2025
Feasibility of implementing an intervention in general practice for deprescribing of glucose-lowering medication in overtreated elderlyCharlotte Andriessen, Marieke T Blom, Beryl A C E van Hoek, et al.Transfusion|May 12, 2025
Vesiculation as potential novel pathogenic mechanism in autoimmune hemolytic anemiaEsther C W de Boer, Femke V M Mulder, Silvia Neri, et al.Cancers|November 25, 2023
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related ToxicitiesJanneke W de Boer, Kylie Keijzer, Elise R A Pennings, et al.Trials|July 25, 2024
A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trialCharlotte Andriessen, Marieke T Blom, Beryl A C E van Hoek, et al.Nature Communications|November 25, 2025
Whole-body CD8<sup>+</sup> T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 studyJanneke W de Boer, Kylie Keijzer, Jaap A van Doesum, et al.Hemasphere|July 15, 2026
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registryAmica K Ko, Pim G N J Mutsaers, Lukas M van Kleij, et al.Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 11, 2017
Short-term Results of the RAPID Randomized Trial of the Legflow Paclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of Intermediate and Long Superficial Femoral Artery LesionsSanne W de Boer, Daniel A F van den Heuvel, Debbie A B de Vries-Werson, et al.Blood Advances|July 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections and survival after CART in R/R LBCLJanneke W. de Boer, Kylie Keijzer, Suzanne van Dorp, et al.Cancers|September 9, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The NetherlandsAnne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, et al.Fungal Systematics and Evolution|August 18, 2022
<i>Fusarium</i> and allied fusarioid taxa (FUSA). 1P W Crous, M Sandoval-Denis, M M Costa, et al.Pageof 46